MEQSEL

MEQSEL

MEQSEL TABLETS
Salt Composition :
TRAMETINIB
Manufacturer :    NOVARTIS INDIA LTD


Available Packs:
MEQSEL 0.5MG (30 TABS IN A BOTTLE)        
  MRP : ₹51410
MEQSEL 2.0MG (30 TABS IN A BOTTLE)          MRP : ₹194000

Prescription Required
There is a Patient Support Program/Patient Assistance Program available in India for this medicine. The program aims to provide eligible patients with access to the medication at a more affordable cost . Please contact your prescribing doctor to know more about the same. You may also call on (9205022032) for more details.

 

Product Description

MEQSEL is an anti-cancer medicine that contains the active substance Trametinib. It is used alone or in combination with other medicines to treat skin cancer called melanoma and cancers with specific genetic mutations. It is also used along with dabrafenib in treating anaplastic thyroid cancer, non-small cell lung cancer, and unresectable or metastatic solid tumors with BRAF V600E mutation.

It belongs to the class of medicines known as kinase inhibitors. It works by blocking a specific enzyme called tyrosine kinase, which helps stop the abnormal growth of cancer cells.

Inform the doctor if you have any infection, bleeding disorders, calcium deficiency, high blood pressure, heart diseases, kidney diseases, liver diseases, seizures or vision problems.

Inform the doctor about all your medical conditions, prescription and non-prescription drugs, vitamin supplements, herbal medications, since MEQSEL can interact with them. MEQSEL can cause an allergic reaction in some patients therefore it is necessary to read the complete composition list and consult the doctor in case of any ingredient that induces allergies.

Consult the doctor if you are planning, on a pregnancy or breastfeeding.

It is advisable to avoid driving and operating heavy machinery during the course of MEQSEL.

Indications of MEQSEL

MEQSEL is indicated to be used alone or in combination with other medicines to treat skin cancer called melanoma and other cancers that have certain genetic mutations. It is also used along with dabrafenib in treating anaplastic thyroid cancer, non-small cell lung cancer, and unresectable or metastatic solid tumors with BRAF V600E mutation.

Therapeutic Effects of MEQSEL

MEQSEL contains Trametinib, a kinase inhibitor is an anti-cancer medication. It works by inhibiting Mitogen-activated extracellular signal-regulated kinase (MEK), which is a key protein in the Mitogen-activated protein kinase (MAPK) pathway. By doing so, it helps to block signals that promote the growth and division of cancer cells. This can slow down or stop the growth of malignant melanoma tumors.

Directions for Use

MEQSEL tablet should be swallowed whole with water and should not be crushed, chewed, or opened. The medicine can be taken with or without food. Taking these medicines regularly at the same time increases their effectiveness. A dose of this medicine should not be missed as it can affect your recovery. Take a missed dose as soon as possible, but skip it if the next dose is near; continue with your regular schedule. This medication may be used in combination with other medications. The dosage and duration of treatment will depend on the individual’s condition and response to the medication.

Your doctor will decide the dose and frequency of administration based on your health condition. Avoid self-medicating.

Storage

  • MEQSEL tablet be stored in refrigerator at 2°C to 8°C. Do not freeze.
  • If you are traveling, carefully follow all patient instructions for storing your medicine during travel. Avoid extreme heat or cold.
  • Keep the injection in the original container to protect from light and moisture.
  • Keep MEQSEL tablet out of sight and reach of children.

Common:

Serious:

Contraindications

Meqsel is contraindicated in patients with a known hypersensitivity to Meqsel or any of the excipients.

Safety Advices for MEQSEL

Consult Your Doctor

It is unknown whether MEQSEL interacts with alcohol. It is best to avoid alcohol or limit your alcohol intake while taking any medication.

Unsafe

MEQSEL is not recommended for use in pregnant women. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking MEQSEL. Your doctor will weigh the benefits and any potential risks before prescribing it to you.

Unsafe

Avoid breastfeeding your baby while on the treatment with MEQSEL, as it may pass through breast milk. Consult your doctor if you are breastfeeding before taking this medication.

Unsafe

MEQSEL may cause fatigue, dizziness, or blurred vision in some patients. Therefore, avoid driving or operating heavy machines that require mental concentration.

Caution

If you have any lung-related symptoms, consult your doctor before taking MEQSEL. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

 

Caution

If you have a pre-existing or a history of liver problems, consult your doctor before taking MEQSEL.  MEQSEL should be used cautiously in patients with hepatic impairment. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor.  MEQSEL should be used cautiously in patients with moderate to severe renal impairment. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Unsafe

MEQSEL is not recommended for use in children below 18 years as the safety and efficacy are not established.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our ‘Platform’, we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user’s risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship. All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.